By the same authors

From the same journal

From the same journal

Fake Drugs: Health, Wealth and Regulation in Nigeria

Research output: Contribution to journalArticle

Standard

Fake Drugs: Health, Wealth and Regulation in Nigeria. / Klantschnig, Gernot; Huang, Chieh.

In: Review of African Political Economy, 20.12.2018.

Research output: Contribution to journalArticle

Harvard

Klantschnig, G & Huang, C 2018, 'Fake Drugs: Health, Wealth and Regulation in Nigeria', Review of African Political Economy. https://doi.org/10.1080/03056244.2018.1536975

APA

Klantschnig, G., & Huang, C. (2018). Fake Drugs: Health, Wealth and Regulation in Nigeria. Review of African Political Economy. https://doi.org/10.1080/03056244.2018.1536975

Vancouver

Klantschnig G, Huang C. Fake Drugs: Health, Wealth and Regulation in Nigeria. Review of African Political Economy. 2018 Dec 20. https://doi.org/10.1080/03056244.2018.1536975

Author

Klantschnig, Gernot ; Huang, Chieh. / Fake Drugs: Health, Wealth and Regulation in Nigeria. In: Review of African Political Economy. 2018.

Bibtex - Download

@article{264db0b0b14644a095b67ad55a2e25e9,
title = "Fake Drugs: Health, Wealth and Regulation in Nigeria",
abstract = "In recent years, international organisations have warned of the lethal trade in fake drugs particularly in Africa. This article assesses how and why fake pharmaceuticals have become a problem in Nigeria and how successful the state has been at regulating it, based on archival, official and interview data. While we show that the early roots of this trade can be found in colonial times, its expansion and growing policy concern were driven by crises in the Nigerian pharmaceutical industry and the healthcare system in the 1980s. In contrast to dominant explanations, we argue that the rise of fake drugs in Nigeria was closely linked to these national crises and related global trends towards market liberalisation and the commodification of health. In this unfavourable context, policies to regulate fake drugs remained limited as they only addressed the symptoms of a more fundamental political and economic problem: the shift from public health towards private wealth and profit-making.",
author = "Gernot Klantschnig and Chieh Huang",
note = "{\textcopyright} 2018 ROAPE Publications Ltd. This is an author-produced version of the published paper. Uploaded in accordance with the publisher{\textquoteright}s self-archiving policy. Further copying may not be permitted; contact the publisher for details.",
year = "2018",
month = dec,
day = "20",
doi = "10.1080/03056244.2018.1536975",
language = "English",
journal = "Review of African Political Economy",
issn = "0305-6244",
publisher = "Routledge",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Fake Drugs: Health, Wealth and Regulation in Nigeria

AU - Klantschnig, Gernot

AU - Huang, Chieh

N1 - © 2018 ROAPE Publications Ltd. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

PY - 2018/12/20

Y1 - 2018/12/20

N2 - In recent years, international organisations have warned of the lethal trade in fake drugs particularly in Africa. This article assesses how and why fake pharmaceuticals have become a problem in Nigeria and how successful the state has been at regulating it, based on archival, official and interview data. While we show that the early roots of this trade can be found in colonial times, its expansion and growing policy concern were driven by crises in the Nigerian pharmaceutical industry and the healthcare system in the 1980s. In contrast to dominant explanations, we argue that the rise of fake drugs in Nigeria was closely linked to these national crises and related global trends towards market liberalisation and the commodification of health. In this unfavourable context, policies to regulate fake drugs remained limited as they only addressed the symptoms of a more fundamental political and economic problem: the shift from public health towards private wealth and profit-making.

AB - In recent years, international organisations have warned of the lethal trade in fake drugs particularly in Africa. This article assesses how and why fake pharmaceuticals have become a problem in Nigeria and how successful the state has been at regulating it, based on archival, official and interview data. While we show that the early roots of this trade can be found in colonial times, its expansion and growing policy concern were driven by crises in the Nigerian pharmaceutical industry and the healthcare system in the 1980s. In contrast to dominant explanations, we argue that the rise of fake drugs in Nigeria was closely linked to these national crises and related global trends towards market liberalisation and the commodification of health. In this unfavourable context, policies to regulate fake drugs remained limited as they only addressed the symptoms of a more fundamental political and economic problem: the shift from public health towards private wealth and profit-making.

U2 - 10.1080/03056244.2018.1536975

DO - 10.1080/03056244.2018.1536975

M3 - Article

JO - Review of African Political Economy

JF - Review of African Political Economy

SN - 0305-6244

ER -